(Q37829355)

24 August 2017

1 reference

title

Suppression of T-cell responses by tumor metabolites (English)

1 reference

24 August 2017

Katrin Singer

1

1 reference

24 August 2017

Eva Gottfried

series ordinal

2

1 reference

24 August 2017

Marina Kreutz

series ordinal

3

1 reference

24 August 2017

Andreas Mackensen

series ordinal

4

1 reference

24 August 2017

15 January 2011

1 reference

Cancer Immunology, Immunotherapy

24 August 2017

1 reference

24 August 2017

60

1 reference

24 August 2017

3

1 reference

24 August 2017

425-431

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-010-0967-1

24 August 2017

0 references

cites work

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

The tumor microenvironment and its role in promoting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Signaling defects in T lymphocytes of patients with malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Regulation of immune responses by L-arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

The role of nitric oxide in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Hypoxia signalling in cancer and approaches to enforce tumour regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

p53 regulates mitochondrial respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucose-degradation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Regulation of T-cell functions by L-lactate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Mutations of the VHL tumour suppressor gene in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Low doses of 2-deoxy-glucose sensitize acute lymphoblastic leukemia cells to glucocorticoid-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0967-1

10.1007/S00262-010-0967-1

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference